Screener
BridgeBio Pharma BBIO Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by BridgeBio Pharma in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The source filing: BridgeBio Pharma’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:31 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001743881-26-000019
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Treasury stock, at cost; 8,678,997 shares as of March 31, 2026; 7,597,172 shares as of December 31, 2025 | (405,776) | (323,276) |
| Additional paid-in capital | 2,112,454 | 2,057,646 |
| Accumulated other comprehensive income (loss) | (8) | 12 |
| Accumulated deficit | (3,985,237) | (3,821,194) |
| Total BridgeBio stockholders’ deficit | (2,278,363) | (2,086,610) |
| Noncontrolling interests | 10,439 | 10,599 |
| Total stockholders’ deficit | (2,267,924) | (2,076,011) |
| Total liabilities, redeemable convertible noncontrolling interests and stockholders’ deficit | $1,370,981 | $936,025 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is BridgeBio Pharma's total liabilities & equity?
- BridgeBio Pharma (BBIO) reported total liabilities & equity of $1.37B in Q1 2026.
- How has BridgeBio Pharma's total liabilities & equity changed year-over-year?
- BridgeBio Pharma's total liabilities & equity increased by 55.5% year-over-year, from $881.64M to $1.37B.
- What is the long-term trend for BridgeBio Pharma's total liabilities & equity?
- Over 5 years (2020 to 2025), BridgeBio Pharma's total liabilities & equity has grown at a 5.9% compound annual growth rate (CAGR), from $703.59M to $936.03M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.
Ask your AI about BridgeBio Pharma's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude